Clinical Trials Browser

Adenocarcinoma × vosaroxin × Clear all

NCT00252382 2018-09-24

Safety and Efficacy Clinical Study of SNS-595 for Second-Line Therapy in Patients With Advanced NSCLC

Phase 2 Completed

31 enrolled 6 charts

Adenocarcinoma, Carcinoma, Carcinoma, Non-Small-Cell Lung, Neoplasms